Yuji Takahashi

Yuji Takahashi


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2017 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
ASAtsuhiko Sugiyama
Atsuhiko Sugiyama
NSN. Sato
N. Sato
YKY. Kimura
Y. Kimura
TMT. Maekawa
T. Maekawa
MEM. Enokizono
M. Enokizono
SKS. Kuwabara
S. Kuwabara
SUMMARY: Neuronal intranuclear inclusion disease is a neurodegenerative disorder pathologically characterized by eosinophilic hyaline intranuclear inclusions. A high-intensity signal along the corticomedullary junction on DWI has been described as a specific MR imaging finding of the cerebrum in neuronal intranuclear inclusion disease. However, MR imaging findings of the cerebellum in neuronal intranuclear inclusion disease have not been fully evaluated. Here, we review MR imaging findings of the cerebellum in a series of 8 patients with pathologically confirmed neuronal intranuclear inclusion disease. The MR imaging results showed cerebellar atrophy (8/8 patients) and high-intensity signal on FLAIR images in the medial part of the cerebellar hemisphere right beside the vermis (the “paravermal area”) (6/8) and in the middle cerebellar peduncle (4/8). The paravermal abnormal signals had a characteristic distribution, and they could be an indicator of the diagnosis of neuronal intranuclear inclusion disease even when using the results of past MR imaging examinations in which DWI findings were not examined.

30 June 2016 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
YKY. Kaichi
Y. Kaichi
KTK. Tanitame
K. Tanitame
HIH. Itakura
H. Itakura
HOH. Ohno
H. Ohno
MYM. Yoneda
M. Yoneda
KAK. Awai
K. Awai
BACKGROUND AND PURPOSE: The quantitative evaluation of orbital fat proliferation and edema and the assessment of extraocular muscles are useful for diagnosing and monitoring thyroid-associated orbitopathy. To evaluate therapy-induced quantitative changes in the orbital fat of patients with thyroid-associated orbitopathy, we performed volumetric and water fraction measurements by using T2-weighted FSE iterative decomposition of water and fat with echo asymmetry and least-squares estimation (FSE-IDEAL) imaging. MATERIALS AND METHODS: Orbital FSE-IDEAL images of 30 volunteers were acquired twice within 1 week. Nine patients with thyroid-associated orbitopathy underwent FSE-IDEAL imaging before and after methylprednisolone pulse therapy, and the treatment results were assessed by using their pre- and post-methylprednisolone pulse therapy clinical activity scores. We performed volumetric and water fraction measurements of orbital fat by using FSE-IDEAL imaging and evaluated interscan differences in the volunteers. In patients with thyroid-associated orbitopathy, we compared pre- and posttherapy orbital fat measurements and assessed the correlation between the pretherapy values and clinical activity score improvement. RESULTS: The reproducibility of results obtained by the quantitative evaluation of orbital fat in volunteers was acceptable. After methylprednisolone pulse therapy, the water fraction in the orbital fat of patients with thyroid-associated orbitopathy was significantly decreased (P < .001). There was a significant positive correlation between the pretherapy water fraction and clinical activity score improvement (right, r = 0.82; left, r = 0.79) and a significant negative correlation between the pretherapy volume and clinical activity score improvement (bilateral, r = −0.84). CONCLUSIONS: Volumetric and water fraction measurements of orbital fat by using FSE-IDEAL imaging are feasible and useful for monitoring the effects of therapy and for predicting the response of patients with thyroid-associated orbitopathy to methylprednisolone pulse therapy.

22 September 2015 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
HNHaruo Nakano
Haruo Nakano
YIYoshitaka Iida
Yoshitaka Iida
MSMakoto Suzuki
Makoto Suzuki
MAMarie Aoki
Marie Aoki
MUMariko Umemura
Mariko Umemura
YTYuji Takahashi
Yuji Takahashi

20 February 2012 in Journal of Molluscan Studies
Verified
Journal Article
Open access
PDF file
YGYasuo Goto
Yasuo Goto
MKMasaaki Kajiwara
Masaaki Kajiwara
YYYuta Yanagisawa
Yuta Yanagisawa
HHHidenori Hirose
Hidenori Hirose
TYTatsuya Yoshimi
Tatsuya Yoshimi
TMTakashi Miura
Takashi Miura
Knowledge of the regulation of molluscan reproductive systems is limited. Many studies have described how the development and maturation of molluscan gonads are regulated by oestrogen. Vertebrate-type oestrogen, 17β-oestradiol, has been detected in molluscs and its concentration in the gonads has been suggested to change in conjunction with reproductive cycles. However, it is unclear if molluscan gonadal tissues are relatively high in aromatase activities. Thais clavigera has been shown to possess a preferential expression of the oestrogen receptor gene in the ovary and ganglia, suggesting an association with gonadal maturation and expression of the oestrogen receptor gene. Therefore, it is interesting to explore the existence of vertebrate-type sex steroid hormones and aromatase activity in T. clavigera. We applied gas chromatography–mass spectrometry techniques to detect steroids in the gonadal tissues of T. clavigera and identified testosterone, androstenedione, 17β-oestradiol and oestrone. The aromatase activities converting androstenedione and testosterone into oestrone and 17β-oestradiol were much higher in gonads than in digestive glands. These data provide insights into the endocrinological system of neogastropods, prompting molecular evidence for the aromatase gene.

3 July 2015 in Bioscience, Biotechnology, and Biochemistry
Verified
Journal Article
Open access
PDF file
MUMariko Umemura
Mariko Umemura
KTKanako Tsunematsu
Kanako Tsunematsu
YSYusuke I Shimizu
Yusuke I Shimizu
HNHaruo Nakano
Haruo Nakano
STShigeru Takahashi
Shigeru Takahashi
YTYuji Takahashi
Yuji Takahashi
Activating transcription factor 5 (ATF5) is a stress response transcription factor of the cAMP-responsive element-binding/ATF family. Earlier, we reported that ATF5 expression is up-regulated in response to stress, such as amino acid limitation or arsenite exposure. Although ATF5 is widely expressed in the brain and the olfactory epithelium, the role of ATF5 is not fully understood. Here, the olfactory bulbs (OBs) of ATF5-deficient mice are smaller than those of wild-type mice. Histological analysis reveals the disturbed laminar structure of the OB, showing the thinner olfactory nerve layer, and a reduced number of interneurons. This is mainly due to the reduced number of bromodeoxyuridine-positive proliferating cells in the subventricular zone, where the interneuron progenitors are formed and migrate to the OBs. Moreover, the olfaction-related aggressive behavior of ATF5-deficient mice is reduced compared to wild-type mice. Our data suggest that ATF5 plays a crucial role in mouse OB development via interneuron.

1 January 2003 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
YTYuji Takahashi
Yuji Takahashi
KSKan Sato
Kan Sato
FIFumiaki Itoh
Fumiaki Itoh
TMToru Miyamoto
Toru Miyamoto
TOTsutai Oohashi
Tsutai Oohashi
NKNorio Katoh
Norio Katoh
Apolipoprotein E (apoE) is a protein constituent of lipoproteins, and acts as a receptor-binding ligand. Although the existence of bovine apoE in lipoprotein fractions has already been reported, quantitative studies on the changes of apoE in plasma and lipoprotein fractions are lacking. In the present study, an increase of a 38 kDa protein in the very low-density lipoprotein (VLDL) fraction obtained from fasted calves was detected. This 38 kDa protein was identified as bovine apoE by determination of the N-terminal amino acid sequence. Bovine apoE was purified and an enzyme-linked immunosorbent assay (ELISA) was developed. Using this system, the effect of fasting on the concentration of apoE in plasma and the distribution of apoE in lipoprotein fractions were investigated. After 3 days of fasting, the concentration of plasma apoE increased significantly (p<0.05) by 280 %, and was returned to the basal level by 3 days of refeeding. The lipoprotein fractions obtained from before and after fasting was separated by ultracentrifugation. ApoE was significantly increased in VLDL, low-density lipoprotein (LDL) and non-lipoprotein fractions by fasting (p<0.05). On the other hand, in high-density lipoprotein (HDL) fractions obtained from both before and after fasting, the level of apoE was very low compared to the other fractions. These results suggested that bovine apoE contents in triglyceride-rich lipoproteins are modulated by nutritional treatment and closely associated with triglyceride-rich lipoprotein metabolism.